Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Seizures 2Glioma 2Glioblastoma 1Epilepsy 1Drug Resistant Epilepsy 1Brain Neoplasms 1

Interventions

Levetiracetam 6Cannabidiol 4perampanel 2Standard of Care 2Everolimus 2enzalutamide 1Vigabatrin 1Tranexamic Acid 1Temozolomide 1Sodium Chloride 1Saline Solution 1Pregabalin 1Medical Marijuana 1Magnesium Sulfate 1Drug Therapy 1Curcumin 1Cholecalciferol 1Aspirin 1Anticonvulsants 1Anastrozole 1Airway Extubation 12-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Seizures × perampanel × Clear all
NCT04497142 2024-08-05

Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Dana-Farber Cancer Institute

Phase 1/2 Completed
12 enrolled 8 charts
CNS

Glioma, Seizures

NCT02363933 2018-04-27

Perampanel in Seizure Patients With Primary Glial Brain Tumors

Duke University

Phase 4 Completed
9 enrolled 9 charts
CNS

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon âš¡